Histopathological comparison of aspiration and biopsy needles in endoscopic ultrasound‐guided tissue acquisition in patients with subepithelial lesions

2021 ◽  
Author(s):  
Masafumi Watanabe ◽  
Kosuke Okuwaki ◽  
Mitsuhiro Kida ◽  
Masayoshi Tadehara ◽  
Kai Adachi ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (5) ◽  
pp. e0154401 ◽  
Author(s):  
Se Woo Park ◽  
Moon Jae Chung ◽  
Sang Hoon Lee ◽  
Hee Seung Lee ◽  
Hyun Jik Lee ◽  
...  


2017 ◽  
Vol 6 (1) ◽  
pp. 73 ◽  
Author(s):  
Filippo Antonini ◽  
Lorenzo Fuccio ◽  
Carlo Fabbri ◽  
Giampiero Macarri


2019 ◽  
Vol 07 (10) ◽  
pp. E1221-E1230 ◽  
Author(s):  
Antonio Facciorusso ◽  
Valentina Del Prete ◽  
Vincenzo Rosario Buccino ◽  
Purvi Purohit ◽  
Puneet Setia ◽  
...  

Abstract Background and study aims Although newer needle designs are thought to improve diagnostic outcomes of endoscopic ultrasound-guided fine-needle biopsy, there is limited evidence on their diagnostic performance. The aim of this meta-analysis was to provide a pooled estimate of the diagnostic performance and safety profile of Franseen and Fork-tip fine-needle biopsy needles. Patients and methods Computerized bibliographic search on the main databases was performed through March 2019. The primary endpoint was sample adequacy. Secondary outcomes were diagnostic accuracy, optimal histological core procurement, mean number of needle passes, pooled specificity and sensitivity. Safety data were also analyzed. Results Twenty-four studies with 6641 patients were included and pancreas was the prevalent location of sampled lesions. Overall sample adequacy with the two newer needles was 94.8 % (93.1 % – 96.4 %), with superiority of Franseen needle over Fork-tip (96.1 % versus 92.4 %, P < 0.001). Sample adequacy in targeting pancreatic masses was 95.6% and both needles produced results superior to fine-needle aspiration (FNA) (odds ratio 4.29, 1.49 – 12.35 and 1.79, 1.01 – 3.19 with Franseen and Fork-tip needle, respectively). The rate of histological core procurement was 92.5%, whereas diagnostic accuracy and sensitivity were 95 % and 92.8 %, again with no difference between the two needles. Number of needle passes was significantly lower in comparison to FNA (mean difference: –0.42 with Franseen and –1.60 with Fork-tip needle). No significant adverse events were registered. Conclusion Our meta-analysis speaks in favor of use of newer biopsy needles as a safe and effective tool in endoscopic ultrasound-guided tissue acquisition.



2017 ◽  
Vol 85 (5) ◽  
pp. AB355-AB356
Author(s):  
Ali Y. Fakhreddine ◽  
Mohammad Shahshahan ◽  
Tahmina Haq ◽  
Daniel Shue ◽  
Anuj Datta ◽  
...  


Gut ◽  
2016 ◽  
Vol 65 (Suppl 1) ◽  
pp. A55.1-A55
Author(s):  
B Paranandi ◽  
KW Oppong ◽  
M Dawwas ◽  
JS Leeds ◽  
A Darne ◽  
...  


Endoscopy ◽  
2018 ◽  
Vol 51 (05) ◽  
pp. 444-451 ◽  
Author(s):  
Alberto Larghi ◽  
Mostafa Ibrahim ◽  
Lorenzo Fuccio ◽  
Selma Lekkerkerker ◽  
Pierre Eisendrath ◽  
...  

Abstract Background A forward-viewing linear (FVL) echoendoscope has been developed with the aim of overcoming some of the limitations of standard curved linear-array (CLA) echoendoscopes. There are no existing studies comparing the performance of the two echoendoscopes for endoscopic ultrasound-guided tissue acquisition (EUS-TA) of solid lesions other than subepithelial lesions. Methods This was a prospective, multicenter, randomized trial with a noninferiority design comparing FVL vs. CLA echoendoscopes in patients with solid lesions of the gastrointestinal tract or adjacent organs. Primary outcomes were successful identification of the lesion and success of EUS-TA. Secondary outcomes were safety, sensitivity, specificity, and diagnostic accuracy of the two different scopes for EUS-TA. Results 126 patients with solid lesions were randomly assigned to the CLA group (63 patients) or the FVL group (63 patients). The two groups were homogeneous with no differences in terms of needle type used, mean number of passes, and site of EUS-TA. No differences were observed between the FVL vs. CLA scopes in identification of the lesion (96.8 % vs. 98.4 %; P > 0.99) and technical success of EUS-TA (92.1 % vs. 96.8 %; P = 0.44). No adverse events occurred. Overall, diagnostic accuracy (77.8 % vs. 84.1 %), sensitivity (76.6 % vs. 84.1 %), and specificity (81.3 % vs. 84.2 %) did not differ between the two groups. Conclusions Our results strongly suggest that the FVL echoendoscope is noninferior to the CLA scope for the detection and performance of EUS-TA in patients with solid lesions of the gastrointestinal tract and adjacent organs. In addition, the FVL scope has the same diagnostic yield, accuracy, and safety as the CLA scope.



2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Inês Pita ◽  
Pedro Pimentel-Nunes ◽  
Mário Dinis-Ribeiro ◽  
Pedro Bastos


Gut and Liver ◽  
2020 ◽  
Vol 14 (3) ◽  
pp. 387-394 ◽  
Author(s):  
Jae Keun Park ◽  
Ji Hyeon Lee ◽  
Dong Hyo Noh ◽  
Joo Kyung Park ◽  
Kyu Taek Lee ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document